Beijing, China

Feng Shao

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Agrobiological Sciences. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Shao. Retrieved from https://idiyas.com/inventor/feng-shao-p7fhdvpk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Feng Shao

Introduction

Feng Shao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology through his innovative research and patent developments. His work focuses on enhancing immune responses, which has important implications for pharmaceutical applications.

Latest Patents

Feng Shao holds a patent for a pharmaceutical composition that promotes immune responses. This composition comprises a 1-ADP-heptose conjugate and may include an immunogen or an immune checkpoint inhibitor. The patent is crucial for developing therapies aimed at boosting the immune system's effectiveness.

Career Highlights

Feng Shao is affiliated with the National Institute of Agrobiological Sciences, where he conducts his research. His work has garnered attention for its potential to advance medical treatments and improve patient outcomes. With a focus on innovative solutions, he continues to contribute to the scientific community.

Collaborations

Feng Shao collaborates with notable colleagues, including Ping Zhou and Yang She. These partnerships enhance the research efforts and foster a collaborative environment that drives innovation.

Conclusion

Feng Shao's contributions to immunology through his patent and research at the National Institute of Agrobiological Sciences highlight his role as a key inventor in the field. His work is paving the way for future advancements in immune response therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…